PAR 2.27% 22.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Pre-AGM Update, page-21

  1. 6 Posts.
    lightbulb Created with Sketch. 1
    Not sure if you know, but the role of a non-executive director should be to provide independent oversight, strategic guidance, and accountability to the company's management team. Do you think she has done that well recently?

    I am assuming, that in Stangelogic's opinion and mine she has most likely not done a good job...A few "big holders" who have some sway probably thought she had not done a good enough job either and "hard a word" i.e had a very difficult conversation with PR about his and her (Hellen's) performance and thinking about it actually most likely the board as a whole.

    To save face and keep what is left of her "reputation" as much as possible she resigned instead of being fired at a later stage when new executives are brought in.

    This is obviously just a guess but it looks this way from the outside looking in. Hope that helps

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.005(2.27%)
Mkt cap ! $78.70M
Open High Low Value Volume
22.8¢ 23.0¢ 22.5¢ $5.077K 22.16K

Buyers (Bids)

No. Vol. Price($)
5 48298 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 9004 5
View Market Depth
Last trade - 11.43am 16/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.